Cooperation of LIM domain‐binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia

Tetsuo Ohnishi(RIKEN), Takeo Yoshikawa(RIKEN Center for Brain Science), Toshihiko Hosoya(Wako University), Masanari Itokawa(Fujita Health University), Chie Shimamoto‐Mitsuyama(RIKEN Center for Brain Science), Kazuhiro Suzuki(National Institute of Health Sciences), Akihiro Nakaya(RIKEN Center for Brain Science), Toshiya Manabe(The University of Tokyo), Motoko Maekawa(RIKEN Center for Brain Science), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Manabu Toyoshima(Sumitomo Chemical (Japan)), Itone Ogawa(Tokyo Metropolitan Institute of Medical Science), Akane Yoshikawa(Tokyo Metropolitan Matsuzawa Hospital), Haruhiko Bito(The University of Tokyo), Kaori Tanaka(Gifu University), Tomoe Ichikawa(Saitama Medical University), Yuji Kiyama(Kagoshima University), Shigehiro Kuraku(National Institute of Genetics), Yayoi Nozaki(RIKEN Center for Brain Science), Tomoko Toyota(RIKEN), Akiko Watanabe(RIKEN Center for Brain Science), Mitsutaka Kadota(Systems Dynamics (United States)), Yasue Horiuchi(National Taiwan University), Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Shabeesh Balan(RIKEN Center for Brain Science), Hiroyuki Okuno(Kagoshima University), Hisako Ohba(RIKEN Center for Brain Science), Kazuyuki Yamada(Wako University), Yoshimi Iwayama(RIKEN), Fumiko Arima‐Yoshida(Jikei University School of Medicine), Rumi Kurokawa(Wako University), Makoto Arai(Tokyo Metropolitan Institute of Medical Science)
EMBO Molecular Medicine
March 3, 2021
Cited by 9


Related Papers